Correlation Between Rekah Pharmaceutical and Elbit Systems

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Elbit Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Elbit Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Elbit Systems, you can compare the effects of market volatilities on Rekah Pharmaceutical and Elbit Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Elbit Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Elbit Systems.

Diversification Opportunities for Rekah Pharmaceutical and Elbit Systems

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Rekah and Elbit is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Elbit Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elbit Systems and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Elbit Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elbit Systems has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Elbit Systems go up and down completely randomly.

Pair Corralation between Rekah Pharmaceutical and Elbit Systems

Assuming the 90 days trading horizon Rekah Pharmaceutical is expected to generate 10.21 times less return on investment than Elbit Systems. In addition to that, Rekah Pharmaceutical is 1.67 times more volatile than Elbit Systems. It trades about 0.02 of its total potential returns per unit of risk. Elbit Systems is currently generating about 0.37 per unit of volatility. If you would invest  7,403,205  in Elbit Systems on August 29, 2024 and sell it today you would earn a total of  1,866,795  from holding Elbit Systems or generate 25.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rekah Pharmaceutical Industry  vs.  Elbit Systems

 Performance 
       Timeline  
Rekah Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rekah Pharmaceutical Industry has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Rekah Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Elbit Systems 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Elbit Systems are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Elbit Systems sustained solid returns over the last few months and may actually be approaching a breakup point.

Rekah Pharmaceutical and Elbit Systems Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rekah Pharmaceutical and Elbit Systems

The main advantage of trading using opposite Rekah Pharmaceutical and Elbit Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Elbit Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elbit Systems will offset losses from the drop in Elbit Systems' long position.
The idea behind Rekah Pharmaceutical Industry and Elbit Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account